Merck expects cancer therapy Keytruda to be part of government price setting in 2026
(Reuters) -Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for ...
MedPage Today23h
BRCA1 Contribution to Prostate Cancer Called Into Question
Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever
The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...
Pfizer: What The Summit Therapeutics Deal Brings
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...
MRK Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Merck & Co., Inc. Securities Class Action
SAN DIEGO, CA / ACCESS Newswire / February 20, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss ...
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Maybe The Ultimate Laggard’
We recently compiled a list of the Jim Cramer Remembers COVID-19 & Discusses These 11 Stocks. In this article, we are going ...
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
Merck Gets Speedy FDA Review of Keytruda in Certain Head, Neck Cancers
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.
Merck & Co. Inc. stock outperforms competitors on strong trading day
Shares of Merck & Co. Inc. MRK rallied 2.08% to $89.50 Friday, on what proved to be an all-around rough trading session for ...
Promising Pharmaceutical Stocks To Follow Today – February 23rd
Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...